Lucid Diagnostics Inc. (LUCD) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Lucid Diagnostics Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -1.92x | -0.91x | -1.12x | -0.88x | -6.90x | -52.54x |
| P/B Ratio | 10.16x | 7.67x | -25.48x | 2.13x | 3.54x | -32.18x |
| P/S Ratio | 23.61x | 9.52x | 24.25x | 130.49x | 387.26x | 0.00x |
| Profitability | ||||||
| Gross Margin | -60.3% | -90.2% | -249.2% | -858.6% | -17.0% | 0.0% |
| Operating Margin | -1054.8% | -1059.6% | -1996.8% | -14899.5% | -5483.8% | 0.0% |
| Net Margin | -1232.7% | -1047.6% | -2169.1% | -14899.5% | -5615.6% | 0.0% |
| EBITDA Margin | -1036.3% | -1020.2% | -2049.1% | -14385.9% | -5483.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 1.31x | 1.07x | 0.75x | 2.89x | 13.45x | 0.09x |
| Quick Ratio | 1.30x | 1.05x | 0.74x | 2.88x | 13.34x | 0.04x |
| Leverage | ||||||
| Debt/Equity | 2.36x | 3.94x | -6.60x | 0.09x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..